I Hameed, MO Khan, K Nusrat, S Mahmood… - American Journal of …, 2023 - Elsevier
Objective To evaluate the safety and efficacy of COVID-19 vaccines in pregnant women performing an updated meta-analysis. Methods We searched PubMed, Cochrane Central …
D Sutton, M D'Alton, Y Zhang, K Kahe, A Cepin… - American journal of …, 2021 - Elsevier
BACKGROUND Although mass vaccination against COVID-19 may prove to be the most efficacious end to this deadly pandemic, there remain concern and indecision among the …
IM Citu, C Citu, F Gorun, I Sas, F Bratosin… - Journal of Clinical …, 2022 - mdpi.com
Clinical trials for COVID-19 vaccines initially excluded pregnant women due to safety concerns, and when the vaccines were authorized for emergency use, they were not …
E Brillo, V Tosto, S Gerli, E Buonomo - The Journal of Maternal …, 2022 - Taylor & Francis
Aim To identify whether COVID-19 vaccines should be administered in pregnant and breastfeeding women by reviewing the guidance and other evidence. Methods We reviewed …
SN Piekos, YM Hwang, RT Roper… - The Lancet Digital …, 2023 - thelancet.com
Background COVID-19 in pregnant people increases the risk for poor maternal–fetal outcomes. However, COVID-19 vaccination hesitancy remains due to concerns over the …
R Wali, H Alhindi, A Saber, K Algethami, R Alhumaidah - Cureus, 2023 - ncbi.nlm.nih.gov
Introduction: The coronavirus disease 2019 (COVID-19) vaccine was developed to stimulate acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
Y Ma, J Deng, Q Liu, M Du, M Liu, J Liu - Vaccines, 2022 - mdpi.com
We aimed to assess the effectiveness and safety of coronavirus disease 2019 (COVID-19) vaccines for pregnant women in real-world studies. We searched for observational studies …
JA Thorp, C Rogers, MP Deskevich, S Tankersley… - 2022 - europepmc.org
Objectives: Assess rates of adverse events (AE) after COVID-19 vaccines experienced by women of reproductive age, focusing on pregnancy and menstruation, using data collected …
L Lu, L Wang, T Feng, X Du - Human Vaccines & …, 2023 - Taylor & Francis
This prospective cohort study aimed to evaluate the safety of an inactivated coronavirus disease 2019 (COVID-19) vaccine in pregnant women at a tertiary hospital in Hubei, China …